Beyond the Cardiomyocyte: Consideration of HIPPO Pathway Cell-Type Specificity.
expert_opinion · Level V
Where this comes from
- Record sourced from PubMed, PMID 29929975.
- Also identified by DOI 10.1161/CIRCRESAHA.118.313383 and PMC identifier 6053276.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Increasing interest in the HIPPO signaling pathway has stemmed largely from its ability to modulate cardioprotection and heart regeneration following injury, responses originating from manipulation within the cardiomyocyte. This viewpoint discusses the need for definitive understanding of HIPPO pathway function in cardiac non-myocytes, and highlights the necessity of considering cell type specificity for effective therapeutic targeting of the HIPPO pathway in cardiovascular disease.
Medical subject headings
- Fibroblasts
- Myocardial Infarction
- Myocardium
- Protein Serine-Threonine Kinases